PUMA BIOTECHNOLOGY, INC. financial data

Symbol
PBYI on Nasdaq
Location
Los Angeles, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 163% % 13%
Quick Ratio 10% % 64%
Debt-to-equity 97% % -66%
Return On Equity 36% % -13%
Return On Assets 18% % 72%
Operating Margin 16% % 19%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 50,391,107 shares 2.7%
Common Stock, Shares, Outstanding 50,384,274 shares 2.7%
Entity Public Float $134,400,000 USD -5%
Common Stock, Value, Issued $5,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 50,339,456 shares 2.7%
Weighted Average Number of Shares Outstanding, Diluted 50,929,893 shares 3.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $211,995,000 USD -13%
Costs and Expenses $178,437,000 USD -16%
Operating Income (Loss) $33,558,000 USD 3.6%
Nonoperating Income (Expense) $2,645,000 USD 66%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $30,913,000 USD 25%
Income Tax Expense (Benefit) $6,178,000 USD -670%
Net Income (Loss) Attributable to Parent $36,978,000 USD 59%
Earnings Per Share, Basic 0 USD/shares 58%
Earnings Per Share, Diluted 0 USD/shares 60%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $53,525,000 USD -20%
Marketable Securities, Current $40,863,000 USD 39%
Cash, Cash Equivalents, and Short-term Investments $88,425,000 USD -1.6%
Accounts Receivable, after Allowance for Credit Loss, Current $33,565,000 USD -39%
Inventory, Net $9,476,000 USD 255%
Other Assets, Current $230,000 USD -2.5%
Assets, Current $143,580,000 USD -8.4%
Deferred Income Tax Assets, Net $7,075,000 USD
Property, Plant and Equipment, Net $305,000 USD -49%
Operating Lease, Right-of-Use Asset $6,147,000 USD 13%
Assets $202,862,000 USD -8.1%
Accounts Payable, Current $6,386,000 USD -15%
Employee-related Liabilities, Current $5,420,000 USD 24%
Accrued Liabilities, Current $37,116,000 USD -27%
Liabilities, Current $82,728,000 USD -25%
Operating Lease, Liability, Noncurrent $4,866,000 USD 65%
Other Liabilities, Noncurrent $0 USD -100%
Liabilities $87,594,000 USD -41%
Accumulated Other Comprehensive Income (Loss), Net of Tax $19,000 USD -27%
Retained Earnings (Accumulated Deficit) $1,297,213,000 USD 2.8%
Stockholders' Equity Attributable to Parent $115,268,000 USD 62%
Liabilities and Equity $202,862,000 USD -8.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $3,612,000 USD -68%
Net Cash Provided by (Used in) Financing Activities $11,332,000 USD
Net Cash Provided by (Used in) Investing Activities $1,531,000 USD
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 50,384,274 shares 2.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $6,189,000 USD 21%
Interest Paid, Excluding Capitalized Interest, Operating Activities $1,917,000 USD -34%
Deferred Tax Assets, Valuation Allowance $7,000,000 USD
Deferred Tax Assets, Gross $351,972,000 USD -5.3%
Operating Lease, Liability $7,336,000 USD -12%
Depreciation $400,000 USD 0%
Payments to Acquire Property, Plant, and Equipment $61,000 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $36,971,000 USD 59%
Lessee, Operating Lease, Liability, to be Paid $9,634,000 USD 7.6%
Property, Plant and Equipment, Gross $6,894,000 USD -20%
Operating Lease, Liability, Current $2,470,000 USD -54%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,248,000 USD -17%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,913,000 USD -68%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 18%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2,298,000 USD 249%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,292,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $232,184,000 USD -3.6%
Current Income Tax Expense (Benefit) $1,010,000 USD 37%
Unrecognized Tax Benefits $3,045,000 USD 8.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,337,000 USD
Operating Lease, Payments $1,621,000 USD 2.7%
Amortization of Intangible Assets $9,700,000 USD 0%
Deferred Tax Assets, Net of Valuation Allowance $8,490,000 USD 177%
Share-based Payment Arrangement, Expense $7,079,000 USD -21%
Interest Expense $13,377,000 USD 9.3%